Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FullerLifeC60 is a U.S.-based consumer health company that markets BioActive C60, a carbon 60 antioxidant product sold primarily as sublingual strips, along with a topical skin cream. The business appears to focus on direct-to-consumer wellness and antioxidant supplementation rather than regulated biopharmaceutical drug development. Its website emphasizes patented or patent-pending formulation claims, oral strip delivery, and consumer wellness benefits tied to oxidative stress and immune support. Publicly available information also shows the company received an FDA warning letter in 2020 related to unapproved COVID-19-related marketing claims. There is no clear evidence that the company operates a conventional biotech or pharma R&D pipeline with clinical-stage therapeutic assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bioactive C60.